The post-progression survival of patients with recurrent or persistent ovarian clear cell carcinoma: results from a randomized phase III study in JGOG3017/GCIG

OBJECTIVE: In this study we sought to investigate the clinical factors that affect post-progression survival (PPS) in patients with recurrent or persistent clear cell carcinoma (CCC). We utilized the JGOG3017/Gynecological Cancer InterGroup data to compare paclitaxel plus carboplatin (TC) and irinot...

Descripción completa

Detalles Bibliográficos
Autores principales: Kondo, Eiji, Tabata, Tsutomu, Suzuki, Nao, Aoki, Daisuke, Yahata, Hideaki, Kotera, Yoshio, Tokuyama, Osamu, Fujiwara, Keiichi, Kimura, Eizo, Terauchi, Fumitoshi, Sumi, Toshiyuki, Okamoto, Aikou, Yaegashi, Nobuo, Enomoto, Takayuki, Sugiyama, Toru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7593225/
https://www.ncbi.nlm.nih.gov/pubmed/33078599
http://dx.doi.org/10.3802/jgo.2020.31.e94

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7593225/
https://www.ncbi.nlm.nih.gov/pubmed/33078599
http://dx.doi.org/10.3802/jgo.2020.31.e94

Ejemplares similares